P-251 Randomized phase II trial of weekly carboplatin/paclitaxel (C/P) versus every-3-week C/P in advanced non-small cell lung cancer (NSCLC): A pure schedule trial
Year: 2003
Type: conference-abstract
Source: Lung Cancer
Authors: Mark A. Socinski, Thomas A. Hensing, Miluska Escudero, Maureen Tynan, Maria Baggstrom, Anastasia Ivanova, J.H. Li, Kamal Bakri
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2024480397